Hershman JM: Clinical application of thyrotropin-releasing hormone . N Engl J Med 290:886-890, 1974;.
Buckman MT, Peake GT: Prolactin in clinical practice . JAMA 236:871-874, 1976;.
McCann SM: Luteinizing-hormone-releasing hormone . N Engl J Med 296:797-802, 1977;.
Malarkey WB: Recently discovered hypothalamic-pituitary hormones . Clin Chem 22:5-15, 1976;.
Siperstein MD, Unger RH, Madison LL: Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients . J Clin Invest 47:1973-1999, 1968;.
Williamson JR, Kilo C: Current status of capillary basement-membrane disease in diabetes mellitus . Diabetes 26:65-75, 1977;.
Cahill GF Jr, Etzwiler DD, Freinkel N: Blood glucose control in diabetes . Diabetes 25:237-239, 1976;.
Siperstein MD, Foster DW, Knowles HC Jr, et al: Control of blood glucose and diabetic vascular disease . N Engl J Med 296:1060-1063, 1977;.
Unger RH, Orci L: Role of glucagon in diabetes . Arch Intern Med 137:482-491, 1977;.
Felig P, Wahren J, Sherwin R, et al: Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus . Diabetes 25:1091-1099, 1976;.
Unger RH: Somatostatinoma . N Engl J Med 296:998-1000, 1977;.
Gerich JE, Lorenzi M, Karam JH, et al: Abnormal pancreatic glucagon secretion and postprandial hyperglycemia in diabetes mellitus . JAMA 234:159-165, 1975;.
Gerich JE: Somatostatin: Its possible role in carbohydrate homeostasis and the treatment of diabetes mellitus . Arch Intern Med 137:659-666, 1977;.
Felig P: Diabetes: New insights and old concepts . Arch Intern Med 137:569-570, 1977;.
Wahren J, Felig P: Influence of somatostatin on carbohydrate disposal and absorption in diabetes mellitus . Lancet 2:1213-1216, 1976;.
Insulin regimens for diabetic ketoacidosis , editorial. Br Med J 1:405-406, 1977;.
Madison LL: Low-dose insulin: A plea for caution . N Engl J Med 294:393-394, 1976;.